<DOC>
	<DOCNO>NCT00755066</DOCNO>
	<brief_summary>Evaluation effect fluticasone propionate v placebo apply nasal spray increase allergen-specific serum IgE level follow nasal exposure recombinant allergen . Nasal spray apply four week start two week nasal provocation serum IgE level follow eight week nasal provocation .</brief_summary>
	<brief_title>Effect Intranasal Corticosteroids Systemic Allergen Specific IgE</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>male female 1850 year age moderate severe allergic rhinitis grass and/or birch pollen least two season accord history sensitization rPhl p 5 rBet v 1 demonstrate UniCAP within range 3.080 kUA/l positive ( wheal diameter &gt; = 3 mm large negative control half histamine control ) SPT rPhl p 5 rBet v 1 20 Âµg/ml willingness comply study protocol write informed consent perennial allergic rhinitis history asthma necessitate treatment FEV1 &lt; 70 % predict value abnormality auscultation heart lung history anaphylaxis severe atopic dermatitis total serum IgE &gt; 2000 kU/l previous ongoing immunotherapy ( subcutaneous sublingual ) grass birch pollen nasal provocation test previous six month know allergy/intolerance fluticasone propionate loratadine know allergy/intolerance cellulose , polysorbate , phenylethyl alcohol , benzalkonium chloride contraindication use INCS : acute chronic infection upper respiratory tract surgery nose previous year hypersensitivity component drug contraindication nasal provocation test acute rhinosinusitis acute allergic reaction immediate type organ nasal polyposis significant nasal anatomical deformity vasomotor rhinitis autoimmune disease , chronic acute infectious disease , malignancy severe psychological disorder treatment systemic topical ( intranasal , inhaled , external ) corticosteroid 3 month prior study treatment immunosuppressant drug 6 month prior study treatment antihistamine disodium cromoglycate 2 week prior study treatment intranasal adrenergic drug 3 day prior study treatment systemic adrenergic drug treatment psychopharmacological drug 2 week prior study cardiovascular pulmonary disease contraindication adrenaline participation clinical trial within previous 3 month pregnant , lactate sexually active woman childbearing potential use medically accept birth control method mental condition render subject unable understand nature , scope possible consequence study , and/or evidence uncooperative attitude know alcohol drug addiction abuse unlikelihood able complete study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>